Form 4: Thermo Fisher Scientific Executive Reports Adjustment in Performance-Based Restricted Stock Units

Joseph R. Holmes, VP & Chief Accounting Officer of Thermo Fisher Scientific, reports an adjustment in the number of shares received from a performance-based restricted stock unit award due to the company's relative total shareholder return.

Summary

• Joseph R. Holmes, VP & Chief Accounting Officer of Thermo Fisher Scientific, filed a Form 4 on March 4, 2025, reporting changes in beneficial ownership of company stock.
• The filing details an adjustment to a performance-based restricted stock unit award granted on February 23, 2022.
• The adjustment resulted in Holmes receiving 33 fewer shares than initially reported due to the company's relative total shareholder return (TSR) over the measurement period from January 1, 2022, to December 31, 2024.
• The third tranche of the award, which vested on February 28, 2025, was adjusted downward by 30% as a result of the company's relative TSR.
• The filing also reports the disposition of common stock to cover tax obligations, with prices at $528.96 per share.
• Following the reported transactions, Holmes beneficially owns 2,301.1195 shares of common stock.

Sentiment

Score: 6

Explanation: The document is neutral in tone, simply reporting a routine adjustment in executive compensation. The adjustment itself is neither overwhelmingly positive nor negative, as it reflects the company's performance relative to its peers.

Negatives

• The adjustment to the performance-based restricted stock unit award resulted in the reporting person receiving fewer shares than initially anticipated.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The adjustment to the restricted stock units reflects the company's performance relative to its peers, which is a common feature of executive compensation plans designed to align management's interests with those of shareholders.

Comparison to Industry Standards

• Performance-based equity compensation is a common practice among publicly traded companies, particularly in the science and technology sectors where Thermo Fisher Scientific operates.
• Companies like Danaher, Agilent Technologies, and Illumina also utilize TSR-based metrics in their executive compensation plans to incentivize long-term value creation.
• The specific adjustment of 30% downward based on TSR performance would need to be benchmarked against industry peers to determine if it is within a typical range.

Stakeholder Impact

• The adjustment to the executive's compensation reflects the company's performance relative to its peers, which can impact shareholder perception of management's effectiveness.
• Employees may view the adjustment as an indicator of the company's overall performance and its impact on compensation structures.

Key Dates